Back to results
US 2026/0308129 A1Published application
Prodrugs of myc inhibitors
AssigneesH. Lee Moffitt Cancer Center and Research Institute, Inc., The Board of Trustees of the University of Illinois
InventorsSeongseok YUN, Daesung LEE
Life of this patent
Estimating the term…
Abstract
Disclosed are prodrugs of MYC inhibitors and methods making and using same.
Claims14
A compound of Formula I:
- wherein
- R1 is OC(O)R2, OC(O)OR2, OC(O)NHR2, OC(O)(CH2)1-3SR2, or OC(O)(CH2)1-3S(O)R2;
- R2 is C2-10 alkenyl, C2-10 alkynyl, C2-10 alkyl substituted with two or more hydroxyl groups, C2-10 alkyl substituted with N(CH3)2, any of which is optionally substituted with one or more R3;
- R3 is C1-6 alkyl, C3-6 cycloalkyl, O-silyl, OC2-10 alkenyl, SC2-10 alkenyl, S(O)C2-10 alkenyl, OC2-10 alkylpolyol, SC2-10 alkylpolyol, S(O)C2-10 alkyl polyol, C1-6 alkylsulfoxide, or (OCH2CH2)nOCH3, where n is from 1 to 200,
- or a pharmaceutically acceptable salt thereof.
2 more elements
Dependencies are inferred from the claim text.